Fate Therapeutics Appoints Christian Weyer as President and Chief Executive Officer
October 15, 2012 - (Fate Therapeutics) - "Fate Therapeutics, Inc. announced today that Christian Weyer, M.D., M.A.S. has been appointed President and Chief Executive Officer and elected to the Company’s Board of Directors, effective immediately. Dr. Weyer joins Fate Therapeutics after a 12-year tenure with Amylin Pharmaceuticals, Inc., where he most recently served as Senior Vice President of Research and Development until the completion of its acquisition by Bristol-Myers Squibb in August 2012. William H. Rastetter, a partner at Venrock who has served as Fate’s interim CEO since November 2011, will remain Chairman of Fate’s Board of Directors." Read Full Article
